Historically, clinical trial distribution was focused on product protection and patient safety at any cost. More recently, there has been a significant shift within the clinical trial sector, which is adopting more cost-effective processes. Kevin Lawler at Peli BioThermal explains how the sector as a whole seems to be looking much more closely at optimisation and cost management.